Chronic Pain Treatment Market Research Report 2024
The market growth is primarily driven by the rising prevalence of chronic conditions, surging geriatric population, and increasing government support toward chronic pain management.
The market growth is primarily driven by the rising prevalence of chronic conditions, surging geriatric population, and increasing government support toward chronic pain management.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Chronic</strong> <strong>Pain</strong> <strong>Treatment</strong> <strong>Market</strong><br />
Based on product, the chronic pain treatment market is bifurcated into drugs and devices. The<br />
category of drugs is further classified into opioids, non-steroidal anti-inflammatory drugs (NSAIDs),<br />
anticonvulsants, antidepressants, and other drugs. Opioids dominate the chronic pain drugs<br />
market, with an estimated contribution of 36.5% revenue in 2018. Opioids are considered one of<br />
the most effective drug classes for the treatment of chronic pain.<br />
On basis of indication, the chronic pain treatment market is categorized into neuropathic pain,<br />
arthritis pain, cancer pain, chronic back pain, migraine, fibromyalgia, and others. According to the<br />
American Academy of <strong>Pain</strong> Medicine (AAPM), chronic pain affects approximately 1.5 billion people<br />
worldwide, on account of the high prevalence of cardiovascular disorders, cancer, and diabetes.<br />
During the forecast period, the market is expected to witness the fastest growth in demand for<br />
pain treatment products for cancer pain, followed by migraine.<br />
Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=chronicpain-treatment-market<br />
Copyright © P&S <strong>Market</strong> <strong>Research</strong>
Change language